title: Management of young breast cancer patients with de novo genetic mutations.
authors.forename: Christine M
authors.initials: CM
authors.lastname: Fisher
authors.forename: Catherine E
authors.initials: CE
authors.lastname: Klein
authors.forename: Laxmi A
authors.initials: LA
authors.lastname: Kondapalli
authors.forename: Anthony D
authors.initials: AD
authors.lastname: Elias
authors.forename: Virginia F
authors.initials: VF
authors.lastname: Borges
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000235:genetics* / Q000473:pathology / Q000628:therapy*; D018270:Carcinoma, Ductal, Breast / Q000235:genetics* / Q000556:secondary / Q000628:therapy*; D003131:Combined Modality Therapy; D019468:Disease Management; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D008408:Mastectomy; D009154:Mutation / Q000235:genetics*; D011379:Prognosis; D016159:Tumor Suppressor Protein p53 / Q000235:genetics*; D055815:Young Adult
chemical_list: D000970:Antineoplastic Agents; C495901:TP53 protein, human; D016159:Tumor Suppressor Protein p53